FindTrial
Sign In

A clinical study of Rodhradhi Gana kwath Yonidhavan in the management of Kaphaj Yonidhawan,candida albicans

An open clinical trial to evaluate the efficacy of Rodhradi gana kwath Yonidhavan in the management of kaphaj yonivyapada(Candida Albicans). - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078822
Enrollment
30
Registered
2024-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N899- Noninflammatory disorder of vagina, unspecified Health Condition 2: B998- Other infectious disease

Interventions

None listed

Sponsors

DrSheetal Vijay Baldota
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Participants of Age group 25 to 45 years 2. Married Woman 3.Participants with Classical sign and symptoms of kaphaj Yonivyapada (Candida Albicans). 4. Diagnosed participants after vaginal smear test of with positive Candidiasis(Candida Albicans).

Exclusion criteria

Exclusion criteria: 1.Pregnant woman. 2.Prolapsed uterus. 3.Sexually Transmitted Diseases (HIV, VDRL) 4. Uncontrolled Diabetes mellitus. 5.Genital Malignancies 6. Participants on oral contraceptives

Design outcomes

Primary

MeasureTime frame
To study safety of rodhradi gana kwath yonidhavan in the management of kaphaj yonivyapada(candida albicans)Timepoint: 8 days—

Secondary

MeasureTime frame
1.To study nidan panchak of kaphaj yoni vyapada 2.To study etiopathogenesis of candidiasis(candida albicans)Timepoint: 8 days—

Countries

India

Contacts

Public ContactDrSheetal Vijay Baldota

Seth Govindji Raoji Ayurved Mahavidhyalaya Solapur

veena.jawale@sgrayurved.edu.in9028244410

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026